Advanced Search:
Equity Index

GBT.PA - GUERBET

€32.85  -0.7 (-2.09%)

Updated: 11:49 May 5, 2024 EST

Next Session's AI Forecast

91.3%

Avg. Accuracy (AI)

€33.98

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

€33.7

GUERBET's Position Within the Medical Devices Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

GUERBET - HISTORICAL DATA 6M

  • Last price

    €32.85

  • Daily change

    €-0.7

  • Previous Close

    €33.55

  • Last Updated

    11:49 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.89 0.55 0.65 0.66 0.32

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.25 1.61 2.13 2.13 1.96

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 20% 81.98% 90.74%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
37.43 1.74% 36.79 5.69% 34.81 39.41% 24.97

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
1.21 85.71 3.14 54.75

GUERBET Technical Analysis News

GUERBET

15, rue des Vanesses
Zone Paris Nord II
Villepinte 93420
France
33 1 45 91 50 00
https://www.guerbet.com

Sectors: Healthcare
Industry: Medical Devices
F. Time Employees: 2920
Description

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.

Corporate Governance

Guerbet SA’s ISS Governance QualityScore as of May 1, 2024 is 8. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 7; Compensation: 10.

GUERBET'S HOLDERS RANK

List of holders with stock participation in GUERBET.

Holder Rank Holder Shares Date Reported % Out Value